The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

54 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.EBI
Heidelberg University
Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids.EBI
Heidelberg University
Discovery of HCV NS5B thumb site I inhibitors: core-refining from benzimidazole to indole scaffold.EBI
Shandong University
Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease.EBI
China Pharmaceutical University
A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.EBI
University of Kwazulu-Natal
C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.EBI
Heidelberg University
Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus.EBI
Wichita State University
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.EBI
Abbott Laboratories
Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase.EBI
Sanford-Burnham Medical Research Institute
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids.EBI
Roche Palo Alto
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides.EBI
Roche Palo Alto
Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.EBI
Institute of Science and Technology
Identification of halosalicylamide derivatives as a novel class of allosteric inhibitors of HCV NS5B polymerase.EBI
Abbott Laboratories
Nanoparticular Inhibitors of Flavivirus Proteases from Zika, West Nile and Dengue Virus Are Cell-Permeable Antivirals.EBI
Freie Universit£T Berlin
Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.EBI
Baylor College of Medicine
Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.EBI
Baylor College of Medicine
A New Class of Dengue and West Nile Virus Protease Inhibitors with Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays.EBI
Heidelberg University
Inhibitors of the Zika virus protease NS2B-NS3.EBI
Australian National University
Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors.EBI
Freie Universit£T Berlin
Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.EBI
Idenix Sarl, An Msd
Backbone modifications in peptidic inhibitors of flaviviral proteases.EBI
Heidelberg University
Peptide-?-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.EBI
Heidelberg University
Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.EBI
Federal University of Alagoas
Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease.EBI
Australian National University
Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors.EBI
Cnrs Umr7258
Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases.EBI
Freie Universit£T Berlin
2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors.EBI
Gwangju Institute of Science and Technology (Gist)
Development of anti-coxsackievirus agents targeting 3C protease.EBI
Gwangju Institute of School of Life Sciences
Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.EBI
Academia Sinica
Targeting the protease of West Nile virus.EBI
Australian National University Canberra
In silico fragment-based drug design with SEED.EBI
University of Z£Rich
Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.EBI
Korea Research Institute of Chemical Technology
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530).EBI
Abbvie
Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors.BDB
Umdnj-New Jersey Medical School
Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.BDB
National Yang-Ming University
Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors.BDB
Irbm, Mrl Rome
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.BDB
Anadys Pharmaceuticals
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.BDB
Anadys Pharmaceuticals
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.BDB
Anadys Pharmaceuticals
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.BDB
Anadys Pharmaceuticals
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.BDB
Anadys Pharmaceuticals
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.BDB
Anadys Pharmaceuticals